nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinorelbine—CYP2D6—Lomustine—brain cancer	0.117	0.282	CbGbCtD
Vinorelbine—CYP2D6—Hydroxyurea—brain cancer	0.0888	0.213	CbGbCtD
Vinorelbine—CYP3A4—Temozolomide—brain cancer	0.0876	0.211	CbGbCtD
Vinorelbine—CYP3A4—Lomustine—brain cancer	0.0745	0.179	CbGbCtD
Vinorelbine—ABCB1—Etoposide—brain cancer	0.0301	0.0722	CbGbCtD
Vinorelbine—CYP3A4—Etoposide—brain cancer	0.018	0.0433	CbGbCtD
Vinorelbine—TUBB4A—hindbrain—brain cancer	0.00444	0.0356	CbGeAlD
Vinorelbine—TUBB8—head—brain cancer	0.00338	0.0272	CbGeAlD
Vinorelbine—TUBB8—central nervous system—brain cancer	0.00309	0.0248	CbGeAlD
Vinorelbine—TUBB4A—brainstem—brain cancer	0.00254	0.0204	CbGeAlD
Vinorelbine—TUBB8—brain—brain cancer	0.00245	0.0197	CbGeAlD
Vinorelbine—TUBB3—head—brain cancer	0.00231	0.0185	CbGeAlD
Vinorelbine—TUBB1—head—brain cancer	0.00226	0.0181	CbGeAlD
Vinorelbine—TUBB4A—telencephalon—brain cancer	0.00226	0.0181	CbGeAlD
Vinorelbine—TUBB2B—telencephalon—brain cancer	0.00218	0.0175	CbGeAlD
Vinorelbine—TUBB3—central nervous system—brain cancer	0.00211	0.0169	CbGeAlD
Vinorelbine—TUBB—telencephalon—brain cancer	0.00206	0.0166	CbGeAlD
Vinorelbine—TUBB1—central nervous system—brain cancer	0.00206	0.0166	CbGeAlD
Vinorelbine—TUBB3—cerebellum—brain cancer	0.00206	0.0165	CbGeAlD
Vinorelbine—TUBB2A—telencephalon—brain cancer	0.00205	0.0165	CbGeAlD
Vinorelbine—TUBB4A—gonad—brain cancer	0.00188	0.0151	CbGeAlD
Vinorelbine—TUBB2B—gonad—brain cancer	0.00182	0.0146	CbGeAlD
Vinorelbine—TUBB2B—pituitary gland—brain cancer	0.00178	0.0143	CbGeAlD
Vinorelbine—TUBB4A—medulla oblongata—brain cancer	0.00177	0.0142	CbGeAlD
Vinorelbine—TUBB4B—telencephalon—brain cancer	0.00176	0.0141	CbGeAlD
Vinorelbine—TUBB2B—medulla oblongata—brain cancer	0.00171	0.0138	CbGeAlD
Vinorelbine—TUBB6—gonad—brain cancer	0.00169	0.0136	CbGeAlD
Vinorelbine—TUBB—pituitary gland—brain cancer	0.00168	0.0135	CbGeAlD
Vinorelbine—TUBB3—brain—brain cancer	0.00167	0.0134	CbGeAlD
Vinorelbine—TUBB2A—pituitary gland—brain cancer	0.00167	0.0134	CbGeAlD
Vinorelbine—TUBB6—pituitary gland—brain cancer	0.00165	0.0132	CbGeAlD
Vinorelbine—TUBB1—brain—brain cancer	0.00164	0.0131	CbGeAlD
Vinorelbine—TUBB—medulla oblongata—brain cancer	0.00162	0.013	CbGeAlD
Vinorelbine—TUBB4A—midbrain—brain cancer	0.00162	0.013	CbGeAlD
Vinorelbine—TUBB2A—medulla oblongata—brain cancer	0.00161	0.013	CbGeAlD
Vinorelbine—TUBB6—medulla oblongata—brain cancer	0.00159	0.0128	CbGeAlD
Vinorelbine—TUBB4A—spinal cord—brain cancer	0.00158	0.0127	CbGeAlD
Vinorelbine—TUBB—Regulation of PLK1 Activity at G2/M Transition—PPP1R12A—brain cancer	0.00158	0.0334	CbGpPWpGaD
Vinorelbine—TUBB2B—midbrain—brain cancer	0.00157	0.0126	CbGeAlD
Vinorelbine—TUBB2B—spinal cord—brain cancer	0.00153	0.0123	CbGeAlD
Vinorelbine—TUBB—midbrain—brain cancer	0.00148	0.0119	CbGeAlD
Vinorelbine—TUBB2A—midbrain—brain cancer	0.00147	0.0118	CbGeAlD
Vinorelbine—TUBB4B—gonad—brain cancer	0.00147	0.0118	CbGeAlD
Vinorelbine—TUBB6—midbrain—brain cancer	0.00145	0.0117	CbGeAlD
Vinorelbine—TUBB—spinal cord—brain cancer	0.00145	0.0116	CbGeAlD
Vinorelbine—TUBB2A—spinal cord—brain cancer	0.00144	0.0116	CbGeAlD
Vinorelbine—TUBB4B—pituitary gland—brain cancer	0.00143	0.0115	CbGeAlD
Vinorelbine—TUBB4A—endocrine gland—brain cancer	0.00142	0.0114	CbGeAlD
Vinorelbine—TUBB6—spinal cord—brain cancer	0.00142	0.0114	CbGeAlD
Vinorelbine—TUBB4A—head—brain cancer	0.00141	0.0113	CbGeAlD
Vinorelbine—CYP2D6—hindbrain—brain cancer	0.0014	0.0112	CbGeAlD
Vinorelbine—TUBB4B—medulla oblongata—brain cancer	0.00138	0.0111	CbGeAlD
Vinorelbine—TUBB2B—endocrine gland—brain cancer	0.00138	0.011	CbGeAlD
Vinorelbine—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.00137	0.029	CbGpPWpGaD
Vinorelbine—TUBB2B—head—brain cancer	0.00136	0.0109	CbGeAlD
Vinorelbine—TUBB4A—Regulation of PLK1 Activity at G2/M Transition—PPP1R12A—brain cancer	0.00131	0.0276	CbGpPWpGaD
Vinorelbine—TUBB2A—endocrine gland—brain cancer	0.0013	0.0104	CbGeAlD
Vinorelbine—TUBB4A—central nervous system—brain cancer	0.00128	0.0103	CbGeAlD
Vinorelbine—TUBB2A—head—brain cancer	0.00128	0.0103	CbGeAlD
Vinorelbine—TUBB6—endocrine gland—brain cancer	0.00128	0.0103	CbGeAlD
Vinorelbine—TUBB2B—Orphan transporters—S100A10—brain cancer	0.00128	0.027	CbGpPWpGaD
Vinorelbine—TUBB6—Orphan transporters—S100A10—brain cancer	0.00128	0.027	CbGpPWpGaD
Vinorelbine—TUBB4B—midbrain—brain cancer	0.00126	0.0102	CbGeAlD
Vinorelbine—TUBB6—head—brain cancer	0.00126	0.0101	CbGeAlD
Vinorelbine—TUBB4A—cerebellum—brain cancer	0.00125	0.0101	CbGeAlD
Vinorelbine—TUBB2B—central nervous system—brain cancer	0.00124	0.00996	CbGeAlD
Vinorelbine—TUBB4B—spinal cord—brain cancer	0.00123	0.0099	CbGeAlD
Vinorelbine—TUBB3—Orphan transporters—S100A10—brain cancer	0.00123	0.0261	CbGpPWpGaD
Vinorelbine—TUBB2B—cerebellum—brain cancer	0.00121	0.00973	CbGeAlD
Vinorelbine—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—PPP1R12A—brain cancer	0.0012	0.0253	CbGpPWpGaD
Vinorelbine—TUBB2A—Orphan transporters—S100A10—brain cancer	0.00119	0.0253	CbGpPWpGaD
Vinorelbine—TUBB—G2/M Transition—PPP1R12A—brain cancer	0.00118	0.025	CbGpPWpGaD
Vinorelbine—TUBB1—Orphan transporters—S100A10—brain cancer	0.00117	0.0247	CbGpPWpGaD
Vinorelbine—TUBB—Mitotic G2-G2/M phases—PPP1R12A—brain cancer	0.00117	0.0247	CbGpPWpGaD
Vinorelbine—TUBB2A—central nervous system—brain cancer	0.00117	0.00937	CbGeAlD
Vinorelbine—TUBB6—central nervous system—brain cancer	0.00115	0.00924	CbGeAlD
Vinorelbine—TUBB—cerebellum—brain cancer	0.00115	0.00921	CbGeAlD
Vinorelbine—TUBB2A—cerebellum—brain cancer	0.00114	0.00916	CbGeAlD
Vinorelbine—TUBB6—cerebellum—brain cancer	0.00113	0.00903	CbGeAlD
Vinorelbine—TUBB4B—endocrine gland—brain cancer	0.00111	0.00892	CbGeAlD
Vinorelbine—TUBB4B—head—brain cancer	0.0011	0.0088	CbGeAlD
Vinorelbine—TUBB8—Parkin-Ubiquitin Proteasomal System pathway—CCNE1—brain cancer	0.00106	0.0223	CbGpPWpGaD
Vinorelbine—ABCB1—blood vessel—brain cancer	0.00106	0.00847	CbGeAlD
Vinorelbine—TUBB4A—Orphan transporters—S100A10—brain cancer	0.00105	0.0222	CbGpPWpGaD
Vinorelbine—TUBB4A—brain—brain cancer	0.00102	0.00818	CbGeAlD
Vinorelbine—TUBB4B—central nervous system—brain cancer	0.001	0.00803	CbGeAlD
Vinorelbine—TUBB2B—brain—brain cancer	0.000984	0.0079	CbGeAlD
Vinorelbine—TUBB4A—G2/M Transition—PPP1R12A—brain cancer	0.000981	0.0208	CbGpPWpGaD
Vinorelbine—TUBB4B—cerebellum—brain cancer	0.000978	0.00785	CbGeAlD
Vinorelbine—TUBB4A—Mitotic G2-G2/M phases—PPP1R12A—brain cancer	0.000968	0.0205	CbGpPWpGaD
Vinorelbine—TUBB4B—Orphan transporters—S100A10—brain cancer	0.000959	0.0203	CbGpPWpGaD
Vinorelbine—Pancytopenia—Hydroxyurea—brain cancer	0.000934	0.00227	CcSEcCtD
Vinorelbine—TUBB—brain—brain cancer	0.000932	0.00748	CbGeAlD
Vinorelbine—TUBB2A—brain—brain cancer	0.000927	0.00744	CbGeAlD
Vinorelbine—Hyponatraemia—Carmustine—brain cancer	0.000924	0.00224	CcSEcCtD
Vinorelbine—Neutropenia—Hydroxyurea—brain cancer	0.00092	0.00223	CcSEcCtD
Vinorelbine—TUBB6—brain—brain cancer	0.000914	0.00734	CbGeAlD
Vinorelbine—Arrhythmia—Procarbazine—brain cancer	0.000909	0.00221	CcSEcCtD
Vinorelbine—Body temperature increased—Lomustine—brain cancer	0.0009	0.00218	CcSEcCtD
Vinorelbine—Alopecia—Procarbazine—brain cancer	0.000899	0.00218	CcSEcCtD
Vinorelbine—TUBB4B—G2/M Transition—PPP1R12A—brain cancer	0.000897	0.019	CbGpPWpGaD
Vinorelbine—Oesophagitis—Etoposide—brain cancer	0.000896	0.00217	CcSEcCtD
Vinorelbine—TUBB4B—Mitotic G2-G2/M phases—PPP1R12A—brain cancer	0.000885	0.0187	CbGpPWpGaD
Vinorelbine—Infestation NOS—Hydroxyurea—brain cancer	0.000877	0.00213	CcSEcCtD
Vinorelbine—Infestation—Hydroxyurea—brain cancer	0.000877	0.00213	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Hydroxyurea—brain cancer	0.00086	0.00209	CcSEcCtD
Vinorelbine—Stomatitis—Hydroxyurea—brain cancer	0.000855	0.00208	CcSEcCtD
Vinorelbine—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000851	0.018	CbGpPWpGaD
Vinorelbine—Sepsis—Etoposide—brain cancer	0.000851	0.00206	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00083	0.00201	CcSEcCtD
Vinorelbine—Phlebitis—Etoposide—brain cancer	0.000826	0.002	CcSEcCtD
Vinorelbine—Anaemia—Procarbazine—brain cancer	0.000819	0.00199	CcSEcCtD
Vinorelbine—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000818	0.0173	CbGpPWpGaD
Vinorelbine—Muscular weakness—Carmustine—brain cancer	0.000812	0.00197	CcSEcCtD
Vinorelbine—TUBB2A—Signaling events mediated by HDAC Class III—SIRT1—brain cancer	0.000808	0.0171	CbGpPWpGaD
Vinorelbine—CYP2D6—brainstem—brain cancer	0.000802	0.00644	CbGeAlD
Vinorelbine—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.000801	0.00194	CcSEcCtD
Vinorelbine—Dysphagia—Carmustine—brain cancer	0.000795	0.00193	CcSEcCtD
Vinorelbine—TUBB4B—brain—brain cancer	0.000794	0.00638	CbGeAlD
Vinorelbine—Leukopenia—Procarbazine—brain cancer	0.000793	0.00192	CcSEcCtD
Vinorelbine—Muscular weakness—Temozolomide—brain cancer	0.000784	0.0019	CcSEcCtD
Vinorelbine—Cough—Procarbazine—brain cancer	0.000773	0.00188	CcSEcCtD
Vinorelbine—Dysphagia—Temozolomide—brain cancer	0.000769	0.00187	CcSEcCtD
Vinorelbine—Hypertension—Procarbazine—brain cancer	0.000765	0.00186	CcSEcCtD
Vinorelbine—Pancytopenia—Carmustine—brain cancer	0.000755	0.00183	CcSEcCtD
Vinorelbine—Arthralgia—Procarbazine—brain cancer	0.000754	0.00183	CcSEcCtD
Vinorelbine—Myalgia—Procarbazine—brain cancer	0.000754	0.00183	CcSEcCtD
Vinorelbine—Neutropenia—Carmustine—brain cancer	0.000744	0.00181	CcSEcCtD
Vinorelbine—Pancytopenia—Temozolomide—brain cancer	0.00073	0.00177	CcSEcCtD
Vinorelbine—Cardiac failure—Etoposide—brain cancer	0.000729	0.00177	CcSEcCtD
Vinorelbine—Vomiting—Lomustine—brain cancer	0.000724	0.00176	CcSEcCtD
Vinorelbine—Neutropenia—Temozolomide—brain cancer	0.000719	0.00174	CcSEcCtD
Vinorelbine—Infection—Procarbazine—brain cancer	0.000718	0.00174	CcSEcCtD
Vinorelbine—Angiopathy—Hydroxyurea—brain cancer	0.000715	0.00173	CcSEcCtD
Vinorelbine—Pneumonia—Carmustine—brain cancer	0.000713	0.00173	CcSEcCtD
Vinorelbine—CYP2D6—telencephalon—brain cancer	0.000712	0.00572	CbGeAlD
Vinorelbine—Thrombocytopenia—Procarbazine—brain cancer	0.000708	0.00172	CcSEcCtD
Vinorelbine—Tachycardia—Procarbazine—brain cancer	0.000706	0.00171	CcSEcCtD
Vinorelbine—Alopecia—Hydroxyurea—brain cancer	0.000696	0.00169	CcSEcCtD
Vinorelbine—Weight decreased—Temozolomide—brain cancer	0.000695	0.00169	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Carmustine—brain cancer	0.000695	0.00169	CcSEcCtD
Vinorelbine—Stomatitis—Carmustine—brain cancer	0.000691	0.00168	CcSEcCtD
Vinorelbine—Pneumonia—Temozolomide—brain cancer	0.000689	0.00167	CcSEcCtD
Vinorelbine—Anorexia—Procarbazine—brain cancer	0.000689	0.00167	CcSEcCtD
Vinorelbine—Erythema—Hydroxyurea—brain cancer	0.000686	0.00166	CcSEcCtD
Vinorelbine—Infestation NOS—Temozolomide—brain cancer	0.000685	0.00166	CcSEcCtD
Vinorelbine—Infestation—Temozolomide—brain cancer	0.000685	0.00166	CcSEcCtD
Vinorelbine—Nausea—Lomustine—brain cancer	0.000676	0.00164	CcSEcCtD
Vinorelbine—Hypotension—Procarbazine—brain cancer	0.000676	0.00164	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Temozolomide—brain cancer	0.000672	0.00163	CcSEcCtD
Vinorelbine—Stomatitis—Temozolomide—brain cancer	0.000668	0.00162	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000659	0.0016	CcSEcCtD
Vinorelbine—Paraesthesia—Procarbazine—brain cancer	0.000649	0.00158	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Temozolomide—brain cancer	0.000648	0.00157	CcSEcCtD
Vinorelbine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000636	0.00154	CcSEcCtD
Vinorelbine—Anaemia—Hydroxyurea—brain cancer	0.000634	0.00154	CcSEcCtD
Vinorelbine—Hypoaesthesia—Carmustine—brain cancer	0.000633	0.00154	CcSEcCtD
Vinorelbine—Decreased appetite—Procarbazine—brain cancer	0.000628	0.00153	CcSEcCtD
Vinorelbine—TUBB8—Pathogenic Escherichia coli infection—CTNNB1—brain cancer	0.000627	0.0133	CbGpPWpGaD
Vinorelbine—Connective tissue disorder—Carmustine—brain cancer	0.000626	0.00152	CcSEcCtD
Vinorelbine—Fatigue—Procarbazine—brain cancer	0.000623	0.00151	CcSEcCtD
Vinorelbine—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00062	0.0131	CbGpPWpGaD
Vinorelbine—Malaise—Hydroxyurea—brain cancer	0.000618	0.0015	CcSEcCtD
Vinorelbine—Constipation—Procarbazine—brain cancer	0.000618	0.0015	CcSEcCtD
Vinorelbine—Pain—Procarbazine—brain cancer	0.000618	0.0015	CcSEcCtD
Vinorelbine—Dysphagia—Etoposide—brain cancer	0.000615	0.00149	CcSEcCtD
Vinorelbine—Leukopenia—Hydroxyurea—brain cancer	0.000614	0.00149	CcSEcCtD
Vinorelbine—Hypoaesthesia—Temozolomide—brain cancer	0.000612	0.00149	CcSEcCtD
Vinorelbine—Bronchospasm—Etoposide—brain cancer	0.000605	0.00147	CcSEcCtD
Vinorelbine—Connective tissue disorder—Temozolomide—brain cancer	0.000605	0.00147	CcSEcCtD
Vinorelbine—Feeling abnormal—Procarbazine—brain cancer	0.000596	0.00145	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Procarbazine—brain cancer	0.000591	0.00143	CcSEcCtD
Vinorelbine—Flushing—Carmustine—brain cancer	0.000591	0.00143	CcSEcCtD
Vinorelbine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000591	0.0125	CbGpPWpGaD
Vinorelbine—Pancytopenia—Etoposide—brain cancer	0.000584	0.00142	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00058	0.00141	CcSEcCtD
Vinorelbine—Discomfort—Hydroxyurea—brain cancer	0.000577	0.0014	CcSEcCtD
Vinorelbine—Neutropenia—Etoposide—brain cancer	0.000575	0.0014	CcSEcCtD
Vinorelbine—Urticaria—Procarbazine—brain cancer	0.000574	0.00139	CcSEcCtD
Vinorelbine—Body temperature increased—Procarbazine—brain cancer	0.000572	0.00139	CcSEcCtD
Vinorelbine—Abdominal pain—Procarbazine—brain cancer	0.000572	0.00139	CcSEcCtD
Vinorelbine—Cardiac disorder—Temozolomide—brain cancer	0.000571	0.00139	CcSEcCtD
Vinorelbine—Flushing—Temozolomide—brain cancer	0.000571	0.00139	CcSEcCtD
Vinorelbine—Arrhythmia—Carmustine—brain cancer	0.000569	0.00138	CcSEcCtD
Vinorelbine—Alopecia—Carmustine—brain cancer	0.000563	0.00137	CcSEcCtD
Vinorelbine—Angiopathy—Temozolomide—brain cancer	0.000558	0.00135	CcSEcCtD
Vinorelbine—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000556	0.0118	CbGpPWpGaD
Vinorelbine—Infection—Hydroxyurea—brain cancer	0.000556	0.00135	CcSEcCtD
Vinorelbine—Immune system disorder—Temozolomide—brain cancer	0.000556	0.00135	CcSEcCtD
Vinorelbine—Mediastinal disorder—Temozolomide—brain cancer	0.000554	0.00135	CcSEcCtD
Vinorelbine—Erythema—Carmustine—brain cancer	0.000554	0.00135	CcSEcCtD
Vinorelbine—Malnutrition—Carmustine—brain cancer	0.000554	0.00135	CcSEcCtD
Vinorelbine—Pneumonia—Etoposide—brain cancer	0.000552	0.00134	CcSEcCtD
Vinorelbine—Nervous system disorder—Hydroxyurea—brain cancer	0.000549	0.00133	CcSEcCtD
Vinorelbine—Infestation NOS—Etoposide—brain cancer	0.000548	0.00133	CcSEcCtD
Vinorelbine—Infestation—Etoposide—brain cancer	0.000548	0.00133	CcSEcCtD
Vinorelbine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000548	0.00133	CcSEcCtD
Vinorelbine—Alopecia—Temozolomide—brain cancer	0.000544	0.00132	CcSEcCtD
Vinorelbine—Skin disorder—Hydroxyurea—brain cancer	0.000543	0.00132	CcSEcCtD
Vinorelbine—Acute coronary syndrome—Etoposide—brain cancer	0.000541	0.00131	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Etoposide—brain cancer	0.000538	0.0013	CcSEcCtD
Vinorelbine—Myocardial infarction—Etoposide—brain cancer	0.000538	0.0013	CcSEcCtD
Vinorelbine—Back pain—Carmustine—brain cancer	0.000536	0.0013	CcSEcCtD
Vinorelbine—Erythema—Temozolomide—brain cancer	0.000536	0.0013	CcSEcCtD
Vinorelbine—Malnutrition—Temozolomide—brain cancer	0.000536	0.0013	CcSEcCtD
Vinorelbine—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000535	0.0113	CbGpPWpGaD
Vinorelbine—Stomatitis—Etoposide—brain cancer	0.000535	0.0013	CcSEcCtD
Vinorelbine—TUBB6—Parkin-Ubiquitin Proteasomal System pathway—CCNE1—brain cancer	0.000534	0.0113	CbGpPWpGaD
Vinorelbine—TUBB2B—Parkin-Ubiquitin Proteasomal System pathway—CCNE1—brain cancer	0.000534	0.0113	CbGpPWpGaD
Vinorelbine—Anorexia—Hydroxyurea—brain cancer	0.000533	0.00129	CcSEcCtD
Vinorelbine—Hypersensitivity—Procarbazine—brain cancer	0.000533	0.00129	CcSEcCtD
Vinorelbine—TUBB—Parkin-Ubiquitin Proteasomal System pathway—CCNE1—brain cancer	0.000529	0.0112	CbGpPWpGaD
Vinorelbine—Asthenia—Procarbazine—brain cancer	0.000519	0.00126	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Etoposide—brain cancer	0.000519	0.00126	CcSEcCtD
Vinorelbine—Back pain—Temozolomide—brain cancer	0.000518	0.00126	CcSEcCtD
Vinorelbine—TUBB3—Parkin-Ubiquitin Proteasomal System pathway—CCNE1—brain cancer	0.000516	0.0109	CbGpPWpGaD
Vinorelbine—Anaemia—Carmustine—brain cancer	0.000512	0.00124	CcSEcCtD
Vinorelbine—ABCB1—telencephalon—brain cancer	0.000512	0.00411	CbGeAlD
Vinorelbine—Agranulocytosis—Etoposide—brain cancer	0.000512	0.00124	CcSEcCtD
Vinorelbine—Pruritus—Procarbazine—brain cancer	0.000511	0.00124	CcSEcCtD
Vinorelbine—TUBB2A—Parkin-Ubiquitin Proteasomal System pathway—CCNE1—brain cancer	0.0005	0.0106	CbGpPWpGaD
Vinorelbine—Dyspnoea—Hydroxyurea—brain cancer	0.000499	0.00121	CcSEcCtD
Vinorelbine—Ill-defined disorder—Temozolomide—brain cancer	0.000497	0.00121	CcSEcCtD
Vinorelbine—Leukopenia—Carmustine—brain cancer	0.000496	0.0012	CcSEcCtD
Vinorelbine—Anaemia—Temozolomide—brain cancer	0.000495	0.0012	CcSEcCtD
Vinorelbine—Diarrhoea—Procarbazine—brain cancer	0.000495	0.0012	CcSEcCtD
Vinorelbine—Hypoaesthesia—Etoposide—brain cancer	0.00049	0.00119	CcSEcCtD
Vinorelbine—Angioedema—Temozolomide—brain cancer	0.000489	0.00119	CcSEcCtD
Vinorelbine—TUBB1—Parkin-Ubiquitin Proteasomal System pathway—CCNE1—brain cancer	0.000489	0.0103	CbGpPWpGaD
Vinorelbine—Decreased appetite—Hydroxyurea—brain cancer	0.000486	0.00118	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000483	0.00117	CcSEcCtD
Vinorelbine—Malaise—Temozolomide—brain cancer	0.000483	0.00117	CcSEcCtD
Vinorelbine—Fatigue—Hydroxyurea—brain cancer	0.000482	0.00117	CcSEcCtD
Vinorelbine—Vertigo—Temozolomide—brain cancer	0.000481	0.00117	CcSEcCtD
Vinorelbine—Leukopenia—Temozolomide—brain cancer	0.000479	0.00116	CcSEcCtD
Vinorelbine—Hypertension—Carmustine—brain cancer	0.000478	0.00116	CcSEcCtD
Vinorelbine—Pain—Hydroxyurea—brain cancer	0.000478	0.00116	CcSEcCtD
Vinorelbine—Constipation—Hydroxyurea—brain cancer	0.000478	0.00116	CcSEcCtD
Vinorelbine—Dizziness—Procarbazine—brain cancer	0.000478	0.00116	CcSEcCtD
Vinorelbine—Palpitations—Temozolomide—brain cancer	0.000473	0.00115	CcSEcCtD
Vinorelbine—Myalgia—Carmustine—brain cancer	0.000472	0.00115	CcSEcCtD
Vinorelbine—Chest pain—Carmustine—brain cancer	0.000472	0.00115	CcSEcCtD
Vinorelbine—Cough—Temozolomide—brain cancer	0.000467	0.00113	CcSEcCtD
Vinorelbine—Hypertension—Temozolomide—brain cancer	0.000462	0.00112	CcSEcCtD
Vinorelbine—Feeling abnormal—Hydroxyurea—brain cancer	0.000461	0.00112	CcSEcCtD
Vinorelbine—Vomiting—Procarbazine—brain cancer	0.00046	0.00112	CcSEcCtD
Vinorelbine—Flushing—Etoposide—brain cancer	0.000457	0.00111	CcSEcCtD
Vinorelbine—Cardiac disorder—Etoposide—brain cancer	0.000457	0.00111	CcSEcCtD
Vinorelbine—CYP3A4—endocrine gland—brain cancer	0.000456	0.00366	CbGeAlD
Vinorelbine—Arthralgia—Temozolomide—brain cancer	0.000456	0.00111	CcSEcCtD
Vinorelbine—Myalgia—Temozolomide—brain cancer	0.000456	0.00111	CcSEcCtD
Vinorelbine—Rash—Procarbazine—brain cancer	0.000456	0.00111	CcSEcCtD
Vinorelbine—Dermatitis—Procarbazine—brain cancer	0.000455	0.00111	CcSEcCtD
Vinorelbine—Headache—Procarbazine—brain cancer	0.000453	0.0011	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000453	0.0011	CcSEcCtD
Vinorelbine—Discomfort—Temozolomide—brain cancer	0.00045	0.00109	CcSEcCtD
Vinorelbine—Infection—Carmustine—brain cancer	0.000449	0.00109	CcSEcCtD
Vinorelbine—CYP2D6—endocrine gland—brain cancer	0.000449	0.0036	CbGeAlD
Vinorelbine—Angiopathy—Etoposide—brain cancer	0.000447	0.00108	CcSEcCtD
Vinorelbine—Immune system disorder—Etoposide—brain cancer	0.000445	0.00108	CcSEcCtD
Vinorelbine—Mediastinal disorder—Etoposide—brain cancer	0.000444	0.00108	CcSEcCtD
Vinorelbine—CYP2D6—head—brain cancer	0.000443	0.00356	CbGeAlD
Vinorelbine—Thrombocytopenia—Carmustine—brain cancer	0.000443	0.00107	CcSEcCtD
Vinorelbine—Body temperature increased—Hydroxyurea—brain cancer	0.000442	0.00107	CcSEcCtD
Vinorelbine—Tachycardia—Carmustine—brain cancer	0.000441	0.00107	CcSEcCtD
Vinorelbine—TUBB4A—Parkin-Ubiquitin Proteasomal System pathway—CCNE1—brain cancer	0.000439	0.00928	CbGpPWpGaD
Vinorelbine—Anaphylactic shock—Temozolomide—brain cancer	0.000437	0.00106	CcSEcCtD
Vinorelbine—Alopecia—Etoposide—brain cancer	0.000435	0.00106	CcSEcCtD
Vinorelbine—Infection—Temozolomide—brain cancer	0.000434	0.00105	CcSEcCtD
Vinorelbine—Anorexia—Carmustine—brain cancer	0.000431	0.00105	CcSEcCtD
Vinorelbine—Nausea—Procarbazine—brain cancer	0.000429	0.00104	CcSEcCtD
Vinorelbine—Nervous system disorder—Temozolomide—brain cancer	0.000429	0.00104	CcSEcCtD
Vinorelbine—Thrombocytopenia—Temozolomide—brain cancer	0.000428	0.00104	CcSEcCtD
Vinorelbine—ABCB1—gonad—brain cancer	0.000427	0.00343	CbGeAlD
Vinorelbine—Skin disorder—Temozolomide—brain cancer	0.000425	0.00103	CcSEcCtD
Vinorelbine—Hypotension—Carmustine—brain cancer	0.000423	0.00103	CcSEcCtD
Vinorelbine—ABCB1—pituitary gland—brain cancer	0.000417	0.00335	CbGeAlD
Vinorelbine—Anorexia—Temozolomide—brain cancer	0.000417	0.00101	CcSEcCtD
Vinorelbine—Back pain—Etoposide—brain cancer	0.000415	0.00101	CcSEcCtD
Vinorelbine—Hypersensitivity—Hydroxyurea—brain cancer	0.000412	0.001	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000412	0.001	CcSEcCtD
Vinorelbine—CYP3A4—central nervous system—brain cancer	0.000411	0.0033	CbGeAlD
Vinorelbine—Paraesthesia—Carmustine—brain cancer	0.000406	0.000986	CcSEcCtD
Vinorelbine—CYP2D6—central nervous system—brain cancer	0.000405	0.00325	CbGeAlD
Vinorelbine—Dyspnoea—Carmustine—brain cancer	0.000403	0.000979	CcSEcCtD
Vinorelbine—ABCB1—medulla oblongata—brain cancer	0.000402	0.00323	CbGeAlD
Vinorelbine—Asthenia—Hydroxyurea—brain cancer	0.000401	0.000974	CcSEcCtD
Vinorelbine—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—CCNE1—brain cancer	0.000401	0.00849	CbGpPWpGaD
Vinorelbine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000398	0.000967	CcSEcCtD
Vinorelbine—Ill-defined disorder—Etoposide—brain cancer	0.000398	0.000965	CcSEcCtD
Vinorelbine—Anaemia—Etoposide—brain cancer	0.000396	0.000961	CcSEcCtD
Vinorelbine—CYP2D6—cerebellum—brain cancer	0.000395	0.00318	CbGeAlD
Vinorelbine—Decreased appetite—Carmustine—brain cancer	0.000393	0.000954	CcSEcCtD
Vinorelbine—Paraesthesia—Temozolomide—brain cancer	0.000392	0.000953	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Carmustine—brain cancer	0.00039	0.000948	CcSEcCtD
Vinorelbine—Dyspnoea—Temozolomide—brain cancer	0.00039	0.000946	CcSEcCtD
Vinorelbine—Constipation—Carmustine—brain cancer	0.000387	0.000939	CcSEcCtD
Vinorelbine—Pain—Carmustine—brain cancer	0.000387	0.000939	CcSEcCtD
Vinorelbine—Malaise—Etoposide—brain cancer	0.000386	0.000938	CcSEcCtD
Vinorelbine—Vertigo—Etoposide—brain cancer	0.000385	0.000935	CcSEcCtD
Vinorelbine—Leukopenia—Etoposide—brain cancer	0.000384	0.000931	CcSEcCtD
Vinorelbine—Diarrhoea—Hydroxyurea—brain cancer	0.000383	0.000929	CcSEcCtD
Vinorelbine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000382	0.00808	CbGpPWpGaD
Vinorelbine—Decreased appetite—Temozolomide—brain cancer	0.00038	0.000922	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000377	0.000916	CcSEcCtD
Vinorelbine—Fatigue—Temozolomide—brain cancer	0.000377	0.000915	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle, Mitotic—PPP1R12A—brain cancer	0.000377	0.00797	CbGpPWpGaD
Vinorelbine—Cough—Etoposide—brain cancer	0.000374	0.000908	CcSEcCtD
Vinorelbine—Constipation—Temozolomide—brain cancer	0.000374	0.000907	CcSEcCtD
Vinorelbine—Pain—Temozolomide—brain cancer	0.000374	0.000907	CcSEcCtD
Vinorelbine—Feeling abnormal—Carmustine—brain cancer	0.000373	0.000905	CcSEcCtD
Vinorelbine—Hypertension—Etoposide—brain cancer	0.00037	0.000898	CcSEcCtD
Vinorelbine—Dizziness—Hydroxyurea—brain cancer	0.00037	0.000898	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Carmustine—brain cancer	0.00037	0.000898	CcSEcCtD
Vinorelbine—ABCB1—midbrain—brain cancer	0.000368	0.00295	CbGeAlD
Vinorelbine—Chest pain—Etoposide—brain cancer	0.000365	0.000886	CcSEcCtD
Vinorelbine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000364	0.0077	CbGpPWpGaD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000362	0.00088	CcSEcCtD
Vinorelbine—Discomfort—Etoposide—brain cancer	0.00036	0.000875	CcSEcCtD
Vinorelbine—Feeling abnormal—Temozolomide—brain cancer	0.00036	0.000874	CcSEcCtD
Vinorelbine—ABCB1—spinal cord—brain cancer	0.000359	0.00288	CbGeAlD
Vinorelbine—Abdominal pain—Carmustine—brain cancer	0.000358	0.000868	CcSEcCtD
Vinorelbine—Body temperature increased—Carmustine—brain cancer	0.000358	0.000868	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Temozolomide—brain cancer	0.000357	0.000868	CcSEcCtD
Vinorelbine—Vomiting—Hydroxyurea—brain cancer	0.000356	0.000863	CcSEcCtD
Vinorelbine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000353	0.00747	CbGpPWpGaD
Vinorelbine—Rash—Hydroxyurea—brain cancer	0.000353	0.000856	CcSEcCtD
Vinorelbine—Dermatitis—Hydroxyurea—brain cancer	0.000352	0.000855	CcSEcCtD
Vinorelbine—Headache—Hydroxyurea—brain cancer	0.000351	0.000851	CcSEcCtD
Vinorelbine—Anaphylactic shock—Etoposide—brain cancer	0.00035	0.000849	CcSEcCtD
Vinorelbine—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000349	0.00738	CbGpPWpGaD
Vinorelbine—Infection—Etoposide—brain cancer	0.000347	0.000843	CcSEcCtD
Vinorelbine—Urticaria—Temozolomide—brain cancer	0.000347	0.000843	CcSEcCtD
Vinorelbine—Abdominal pain—Temozolomide—brain cancer	0.000346	0.000839	CcSEcCtD
Vinorelbine—Body temperature increased—Temozolomide—brain cancer	0.000346	0.000839	CcSEcCtD
Vinorelbine—Thrombocytopenia—Etoposide—brain cancer	0.000342	0.000831	CcSEcCtD
Vinorelbine—Tachycardia—Etoposide—brain cancer	0.000341	0.000829	CcSEcCtD
Vinorelbine—Skin disorder—Etoposide—brain cancer	0.00034	0.000825	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—PPP1R12A—brain cancer	0.000337	0.00712	CbGpPWpGaD
Vinorelbine—Anorexia—Etoposide—brain cancer	0.000333	0.000809	CcSEcCtD
Vinorelbine—Hypersensitivity—Carmustine—brain cancer	0.000333	0.000809	CcSEcCtD
Vinorelbine—Nausea—Hydroxyurea—brain cancer	0.000332	0.000807	CcSEcCtD
Vinorelbine—Hypotension—Etoposide—brain cancer	0.000327	0.000793	CcSEcCtD
Vinorelbine—Asthenia—Carmustine—brain cancer	0.000325	0.000788	CcSEcCtD
Vinorelbine—ABCB1—endocrine gland—brain cancer	0.000323	0.00259	CbGeAlD
Vinorelbine—Hypersensitivity—Temozolomide—brain cancer	0.000322	0.000782	CcSEcCtD
Vinorelbine—CYP2D6—brain—brain cancer	0.000321	0.00258	CbGeAlD
Vinorelbine—ABCB1—head—brain cancer	0.000319	0.00256	CbGeAlD
Vinorelbine—TUBB6—Pathogenic Escherichia coli infection—CTNNB1—brain cancer	0.000317	0.00671	CbGpPWpGaD
Vinorelbine—TUBB2B—Pathogenic Escherichia coli infection—CTNNB1—brain cancer	0.000317	0.00671	CbGpPWpGaD
Vinorelbine—TUBB—Pathogenic Escherichia coli infection—CTNNB1—brain cancer	0.000314	0.00665	CbGpPWpGaD
Vinorelbine—Paraesthesia—Etoposide—brain cancer	0.000314	0.000762	CcSEcCtD
Vinorelbine—Asthenia—Temozolomide—brain cancer	0.000314	0.000761	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—PPP1R12A—brain cancer	0.000312	0.0066	CbGpPWpGaD
Vinorelbine—Dyspnoea—Etoposide—brain cancer	0.000312	0.000757	CcSEcCtD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—S100A10—brain cancer	0.000312	0.00659	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—S100A10—brain cancer	0.000312	0.00659	CbGpPWpGaD
Vinorelbine—Diarrhoea—Carmustine—brain cancer	0.000309	0.000751	CcSEcCtD
Vinorelbine—Pruritus—Temozolomide—brain cancer	0.000309	0.000751	CcSEcCtD
Vinorelbine—TUBB3—Pathogenic Escherichia coli infection—CTNNB1—brain cancer	0.000306	0.00648	CbGpPWpGaD
Vinorelbine—Decreased appetite—Etoposide—brain cancer	0.000304	0.000738	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Etoposide—brain cancer	0.000302	0.000733	CcSEcCtD
Vinorelbine—Fatigue—Etoposide—brain cancer	0.000302	0.000732	CcSEcCtD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—S100A10—brain cancer	0.000301	0.00637	CbGpPWpGaD
Vinorelbine—Dizziness—Carmustine—brain cancer	0.000299	0.000726	CcSEcCtD
Vinorelbine—Pain—Etoposide—brain cancer	0.000299	0.000726	CcSEcCtD
Vinorelbine—Constipation—Etoposide—brain cancer	0.000299	0.000726	CcSEcCtD
Vinorelbine—Diarrhoea—Temozolomide—brain cancer	0.000299	0.000726	CcSEcCtD
Vinorelbine—TUBB2A—Pathogenic Escherichia coli infection—CTNNB1—brain cancer	0.000297	0.00628	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—S100A10—brain cancer	0.000292	0.00617	CbGpPWpGaD
Vinorelbine—ABCB1—central nervous system—brain cancer	0.000291	0.00234	CbGeAlD
Vinorelbine—TUBB1—Pathogenic Escherichia coli infection—CTNNB1—brain cancer	0.00029	0.00614	CbGpPWpGaD
Vinorelbine—Dizziness—Temozolomide—brain cancer	0.000289	0.000702	CcSEcCtD
Vinorelbine—Feeling abnormal—Etoposide—brain cancer	0.000288	0.0007	CcSEcCtD
Vinorelbine—Vomiting—Carmustine—brain cancer	0.000288	0.000698	CcSEcCtD
Vinorelbine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000286	0.00606	CbGpPWpGaD
Vinorelbine—Gastrointestinal pain—Etoposide—brain cancer	0.000286	0.000694	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—PPP1R12A—brain cancer	0.000285	0.00604	CbGpPWpGaD
Vinorelbine—Rash—Carmustine—brain cancer	0.000285	0.000692	CcSEcCtD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000285	0.00603	CbGpPWpGaD
Vinorelbine—Dermatitis—Carmustine—brain cancer	0.000285	0.000692	CcSEcCtD
Vinorelbine—ABCB1—cerebellum—brain cancer	0.000284	0.00228	CbGeAlD
Vinorelbine—Headache—Carmustine—brain cancer	0.000283	0.000688	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—PPP1R12A—brain cancer	0.000279	0.0059	CbGpPWpGaD
Vinorelbine—Vomiting—Temozolomide—brain cancer	0.000278	0.000675	CcSEcCtD
Vinorelbine—Urticaria—Etoposide—brain cancer	0.000278	0.000674	CcSEcCtD
Vinorelbine—Abdominal pain—Etoposide—brain cancer	0.000276	0.000671	CcSEcCtD
Vinorelbine—Body temperature increased—Etoposide—brain cancer	0.000276	0.000671	CcSEcCtD
Vinorelbine—Rash—Temozolomide—brain cancer	0.000276	0.000669	CcSEcCtD
Vinorelbine—Dermatitis—Temozolomide—brain cancer	0.000275	0.000668	CcSEcCtD
Vinorelbine—Headache—Temozolomide—brain cancer	0.000274	0.000665	CcSEcCtD
Vinorelbine—Nausea—Carmustine—brain cancer	0.000269	0.000652	CcSEcCtD
Vinorelbine—TUBB4A—Pathogenic Escherichia coli infection—CTNNB1—brain cancer	0.000261	0.00551	CbGpPWpGaD
Vinorelbine—TUBB2A—Signaling events mediated by HDAC Class III—TP53—brain cancer	0.00026	0.0055	CbGpPWpGaD
Vinorelbine—Nausea—Temozolomide—brain cancer	0.00026	0.00063	CcSEcCtD
Vinorelbine—Hypersensitivity—Etoposide—brain cancer	0.000258	0.000625	CcSEcCtD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—S100A10—brain cancer	0.000256	0.00542	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—PPP1R12A—brain cancer	0.000255	0.0054	CbGpPWpGaD
Vinorelbine—Asthenia—Etoposide—brain cancer	0.000251	0.000609	CcSEcCtD
Vinorelbine—Pruritus—Etoposide—brain cancer	0.000247	0.000601	CcSEcCtD
Vinorelbine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000242	0.00511	CbGpPWpGaD
Vinorelbine—Diarrhoea—Etoposide—brain cancer	0.000239	0.000581	CcSEcCtD
Vinorelbine—TUBB4B—Pathogenic Escherichia coli infection—CTNNB1—brain cancer	0.000238	0.00504	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—S100A10—brain cancer	0.000234	0.00495	CbGpPWpGaD
Vinorelbine—Dizziness—Etoposide—brain cancer	0.000231	0.000561	CcSEcCtD
Vinorelbine—ABCB1—brain—brain cancer	0.000231	0.00186	CbGeAlD
Vinorelbine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000231	0.00489	CbGpPWpGaD
Vinorelbine—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000228	0.00482	CbGpPWpGaD
Vinorelbine—Vomiting—Etoposide—brain cancer	0.000222	0.00054	CcSEcCtD
Vinorelbine—Rash—Etoposide—brain cancer	0.000221	0.000535	CcSEcCtD
Vinorelbine—Dermatitis—Etoposide—brain cancer	0.00022	0.000535	CcSEcCtD
Vinorelbine—Headache—Etoposide—brain cancer	0.000219	0.000532	CcSEcCtD
Vinorelbine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000215	0.00455	CbGpPWpGaD
Vinorelbine—Nausea—Etoposide—brain cancer	0.000208	0.000504	CcSEcCtD
Vinorelbine—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000196	0.00415	CbGpPWpGaD
Vinorelbine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000187	0.00396	CbGpPWpGaD
Vinorelbine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000174	0.00368	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—SKP2—brain cancer	0.000171	0.00362	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—SKP2—brain cancer	0.000153	0.00323	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDK6—brain cancer	0.000152	0.00322	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—CYP2C9—brain cancer	0.000152	0.00322	CbGpPWpGaD
Vinorelbine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000151	0.00319	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	0.00015	0.00317	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000144	0.00305	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000144	0.00305	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—SKP2—brain cancer	0.000142	0.003	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000139	0.00294	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CDK6—brain cancer	0.000136	0.00288	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000135	0.00285	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000132	0.00279	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—SKP2—brain cancer	0.00013	0.00274	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—SKP2—brain cancer	0.000127	0.00268	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDK6—brain cancer	0.000126	0.00267	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000118	0.0025	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—SKP2—brain cancer	0.000116	0.00245	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDK6—brain cancer	0.000116	0.00244	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CCNE1—brain cancer	0.000115	0.00243	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDK6—brain cancer	0.000113	0.00239	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000108	0.00229	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—BRCA2—brain cancer	0.000106	0.00224	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDK6—brain cancer	0.000103	0.00219	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—PDGFRA—brain cancer	0.000103	0.00218	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CCNE1—brain cancer	0.000103	0.00217	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—PCNA—brain cancer	0.000102	0.00215	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—CYP2C9—brain cancer	9.95e-05	0.0021	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	9.81e-05	0.00208	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CCNE1—brain cancer	9.51e-05	0.00201	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—PCNA—brain cancer	9.09e-05	0.00192	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDK4—brain cancer	8.79e-05	0.00186	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—BRCA2—brain cancer	8.78e-05	0.00186	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CCNE1—brain cancer	8.7e-05	0.00184	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	8.58e-05	0.00182	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CCNE1—brain cancer	8.51e-05	0.0018	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—PCNA—brain cancer	8.43e-05	0.00178	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	8.14e-05	0.00172	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—BRCA2—brain cancer	8.03e-05	0.0017	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CDK4—brain cancer	7.86e-05	0.00166	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CCNE1—brain cancer	7.78e-05	0.00165	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—PCNA—brain cancer	7.71e-05	0.00163	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—PCNA—brain cancer	7.54e-05	0.00159	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDK4—brain cancer	7.29e-05	0.00154	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	7.12e-05	0.00151	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—PCNA—brain cancer	6.89e-05	0.00146	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	6.87e-05	0.00145	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDKN2A—brain cancer	6.72e-05	0.00142	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDK4—brain cancer	6.66e-05	0.00141	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDK4—brain cancer	6.51e-05	0.00138	CbGpPWpGaD
Vinorelbine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	6.43e-05	0.00136	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CDKN2A—brain cancer	6.01e-05	0.00127	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDK4—brain cancer	5.96e-05	0.00126	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CCND1—brain cancer	5.68e-05	0.0012	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	5.64e-05	0.00119	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—IL2—brain cancer	5.61e-05	0.00119	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDKN2A—brain cancer	5.57e-05	0.00118	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	5.53e-05	0.00117	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	5.51e-05	0.00117	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	5.46e-05	0.00116	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDKN2A—brain cancer	5.09e-05	0.00108	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	5.08e-05	0.00107	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CCND1—brain cancer	5.08e-05	0.00107	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDKN2A—brain cancer	4.98e-05	0.00105	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	4.84e-05	0.00102	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—VEGFA—brain cancer	4.77e-05	0.00101	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CCND1—brain cancer	4.7e-05	0.000995	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—MYC—brain cancer	4.55e-05	0.000963	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDKN2A—brain cancer	4.55e-05	0.000963	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CCND1—brain cancer	4.3e-05	0.00091	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—CTNNB1—brain cancer	4.23e-05	0.000894	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—CTNNB1—brain cancer	4.23e-05	0.000894	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CCND1—brain cancer	4.21e-05	0.00089	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	4.18e-05	0.000885	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—CTNNB1—brain cancer	4.08e-05	0.000864	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—MYC—brain cancer	4.07e-05	0.000861	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—CTNNB1—brain cancer	3.96e-05	0.000837	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	3.94e-05	0.000833	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—CTNNB1—brain cancer	3.87e-05	0.000818	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CCND1—brain cancer	3.85e-05	0.000814	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—MYC—brain cancer	3.77e-05	0.000798	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—CTNNB1—brain cancer	3.47e-05	0.000734	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—MYC—brain cancer	3.45e-05	0.00073	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—MYC—brain cancer	3.37e-05	0.000714	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—TP53—brain cancer	3.34e-05	0.000707	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	3.29e-05	0.000695	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—CTNNB1—brain cancer	3.18e-05	0.000672	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—MYC—brain cancer	3.09e-05	0.000653	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	3.06e-05	0.000647	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—TP53—brain cancer	2.77e-05	0.000586	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP2C9—brain cancer	2.76e-05	0.000584	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	2.7e-05	0.000571	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	2.67e-05	0.000566	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP2C9—brain cancer	2.6e-05	0.00055	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—TP53—brain cancer	2.53e-05	0.000536	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	2.35e-05	0.000498	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—BSG—brain cancer	2.35e-05	0.000497	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—BSG—brain cancer	2.21e-05	0.000468	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	2.17e-05	0.000458	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	2.12e-05	0.000448	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—IDH1—brain cancer	2.02e-05	0.000427	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—IDH1—brain cancer	1.9e-05	0.000402	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.78e-05	0.000376	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP2C9—brain cancer	1.7e-05	0.00036	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ENO2—brain cancer	1.6e-05	0.000338	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ENO2—brain cancer	1.5e-05	0.000318	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—BSG—brain cancer	1.45e-05	0.000306	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—IDH1—brain cancer	1.24e-05	0.000263	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ENO2—brain cancer	9.83e-06	0.000208	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CG—brain cancer	7.32e-06	0.000155	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CG—brain cancer	6.9e-06	0.000146	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CG—brain cancer	4.51e-06	9.54e-05	CbGpPWpGaD
